In the case of other genes (i.e., those not belonging to the major histocompatibility complex) whose variations influence the risk of developing RA, particular attention should be given to polymorphisms in the FCRL3 promoter region—specifically, single-nucleotide changes in this area. This evidence concerns the gene FCRL3 and rheumatoid arthritis.